Phase 1 study to Investigate the Safety and Immunogenicity of a Combined Respiratory Syncytial Virus/human Metapneumovirus/Parainfluenza Virus type 3 investigational mRNA Vaccine Candidate in Adult Participants Aged 60 Years and Older.
This study is being conducted at our Western Sydney, Central Coast and Brisbane sites.
Apply Now
A Phase 3 study investigating the efficacy and long-term safety of the experimental, modified inhaler with a climate friendly propellant HFA-152a in comparison to the currently approved inhaler with propellant HFA-134a in participants aged 18 years and over with diagnosed asthma.
This study is being being conducted at our Central Coast site
Apply Now
Research study investigating a new cholesterol medication on reducing cardiovascular events in individuals living with, or at risk of cardiovascular disease.
This study is being conducted at our Canberra site.
Apply Now
